A genetic change associated with shorter stature and increased risk of arthritis might have helped our ancestors survive the Ice Age, a study has showed.
The findings showed that mutations in the gene called GDF5 resulted in shorter bones that led to a compact body structure while reducing the risk of bone fracture from falling.
Thus, it also favoured early humans to better withstand frostbite as well as helped them migrate from Africa to colder northern climates between 50,000 and 100,000 years ago.
These advantages in dealing with chilly temperatures and icy surfaces may have outweighed the threat of osteoarthritis, which usually occurs after a prime reproductive age, the researchers said.
"The variant that decreases height is lowering the activity of GDF5 in the growth plates of the bone. Interestingly, the region that harbours this variant is closely linked to other mutations that affect GDF5 activity in the joints, increasing the risk of osteoarthritis in the knee and hip," said Terence Capellini, Associate Professor at the Harvard University.
For the study, published in the journal Nature, the team examined gene GDF5 -- first linked to skeletal growth in the early 1990s -- to learn more about how the DNA sequences surrounding GDF5 might affect the gene's expression.
They identified a single nucleotide change that is highly prevalent in Europeans and Asians but rarely occurs in Africans.
Introducing this nucleotide change into laboratory mice revealed that it decreased the activity of GDF5 in the growth plates of the long bones of foetal mice.
"The potential medical impact of the finding is very interesting because so many people are affected," said David Kingsley, Professor at the Stanford University.
"This is an incredibly prevalent, and ancient, variant. Many people think of osteoarthritis as a kind of wear-and-tear disease, but there's clearly a genetic component at work here as well. Now we've shown that positive evolutionary selection has given rise to one of the most common height variants and arthritis risk factors known in human populations," Kingsley said.
--IANS
rt/him/vt
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
